NRx Pharmaceuticals, Inc.

Healthcare · Biotechnology · United States

Last price 2.66 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 115.08M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments. The company develops NRX-101, an oral fixed-dose combination of D-cycloserine (DCS) and lurasidone in Phase 2/3 clinical testing for bipolar depression with sub-acute ideation and behavior; NRX-100, a preservative-free formulation of ketamine for in...